Paget disease of the breast: A national retrospective analysis of the US population.


Journal

Breast disease
ISSN: 1558-1551
Titre abrégé: Breast Dis
Pays: Netherlands
ID NLM: 8801277

Informations de publication

Date de publication:
2020
Historique:
pubmed: 12 5 2020
medline: 9 7 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

Paget's disease of the breast is rare. The National Cancer Database (NCDB) is one of the largest tumor databases in the United States. We queried the NCDB to identify male and female patients with Paget's disease of the breast who were treated from January 1, 2004, through December 31, 2015. No age limitations were applied. Descriptive statistical analysis and survival analysis were performed. We analyzed the demographic, disease, and treatment characteristics of 7,191 patients with Paget's disease of the breast. The median (range) age was 64 (20-90) years. Only 2.1% of patients were men, and 85.4% were white. The most common treatment was complete mastectomy (65.3%), followed by partial mastectomy (30.3%). Tumor destruction was performed in 0.1% of patients, and 4.3% of patients did not undergo any surgery. We examined survival in the subset of 6,864 patients who were treated surgically with complete mastectomy or partial mastectomy. The 5-year survival rate after surgery was 82.5% (95% CI, 81.1%-83.9%). Factors associated with shorter survival were older age, black race/ethnicity, higher tumor grade, regional lymph node metastasis, higher cancer stage, metastatic cancer, and larger tumor size. Paget's disease of the breast usually affects patients older than 60 years, and the most common treatment is complete mastectomy. The 5-year overall survival rate of patients with Paget's disease of the breast is greater than 80% but is lower among older and black people.

Sections du résumé

BACKGROUND BACKGROUND
Paget's disease of the breast is rare. The National Cancer Database (NCDB) is one of the largest tumor databases in the United States.
METHODS METHODS
We queried the NCDB to identify male and female patients with Paget's disease of the breast who were treated from January 1, 2004, through December 31, 2015. No age limitations were applied. Descriptive statistical analysis and survival analysis were performed.
RESULTS RESULTS
We analyzed the demographic, disease, and treatment characteristics of 7,191 patients with Paget's disease of the breast. The median (range) age was 64 (20-90) years. Only 2.1% of patients were men, and 85.4% were white. The most common treatment was complete mastectomy (65.3%), followed by partial mastectomy (30.3%). Tumor destruction was performed in 0.1% of patients, and 4.3% of patients did not undergo any surgery. We examined survival in the subset of 6,864 patients who were treated surgically with complete mastectomy or partial mastectomy. The 5-year survival rate after surgery was 82.5% (95% CI, 81.1%-83.9%). Factors associated with shorter survival were older age, black race/ethnicity, higher tumor grade, regional lymph node metastasis, higher cancer stage, metastatic cancer, and larger tumor size.
CONCLUSIONS CONCLUSIONS
Paget's disease of the breast usually affects patients older than 60 years, and the most common treatment is complete mastectomy. The 5-year overall survival rate of patients with Paget's disease of the breast is greater than 80% but is lower among older and black people.

Identifiants

pubmed: 32390594
pii: BD200439
doi: 10.3233/BD-200439
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-126

Auteurs

Andrea Sisti (A)

Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA.

Maria T Huayllani (MT)

Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA.

David J Restrepo (DJ)

Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA.

Daniel Boczar (D)

Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA.

Pooja Advani (P)

Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.

Xiaona Lu (X)

Division of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT, USA.

Aaron C Spaulding (AC)

Department of Health Science Research, Mayo Clinic, Jacksonville, FL, USA.

Colleen T Ball (CT)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA.

Sarah A McLaughlin (SA)

Department of Surgery, Mayo Clinic, Jacksonville, FL, USA.

Antonio J Forte (AJ)

Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH